Adjuvant Anal Imiquimod Therapy in Anal HPV-lesions: AdAM-trial

Summary

AdAM is a prospective, randomized, controlled, double-blinded, monocentric trial in patients receiving surgical therapy due to anal HPV infection. Aim of the study is to evaluate efficacy of combination therapy (surgical therapy + topical Imiquimod-therapy). It is planned to include 200 patients. 100 patients receive surgical therapy+ topical Imiquimod therapy, 100 patients receive surgical therapy + topical Placebo therapy

Timeline

Start

2021-11-15

Primary completion

2024-11-15

Completion

2024-11-15

Drugs

Indications